Bank Of Montreal Bellus Health Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 13, 2024	BUY	$7.14 - $8.53 $2.05 Million - $2.45 Million	287,446 New	287,446 $2.07 Million
Q4 2022 Feb 01, 2023	BUY	$8.22 - $10.76 $27,027 - $35,378	3,288 Added 1.05%	316,882 $2.6 Million
Q3 2022 Nov 10, 2022	BUY	$8.95 - $12.0 $2.81 Million - $3.76 Million	313,594 New	313,594 $3.32 Million
Q3 2021 Nov 12, 2021	SELL	$2.7 - $6.64 $36,223 - $89,082	-13,416 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.11 - $4.61 $41,723 - $61,847	13,416 New	13,416 $44,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.